BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhao ZH, Fan YC, Yang Y, Wang K. Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2013; 19(41): 7189-7196 [PMID: 24222965 DOI: 10.3748/wjg.v19.i41.7189]
URL: https://www.wjgnet.com/1948-5182/full/v19/i41/7189.htm
Number Citing Articles
1
Gang Xu, Xiaoxiang Zhou, Jiali Xing, Yao Xiao, Bao Jin, Lejia Sun, Huayu Yang, Shunda Du, Haifeng Xu, Yilei Mao. Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinomaCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01638-5
2
Tekeba Sisay, Mezgebu Abunie. The potential of circulating tumor DNA to use as a molecular marker to screen and diagnose hepatocellular carcinoma: A systematic reviewIP Journal of Diagnostic Pathology and Oncology 2020; 5(4): 361 doi: 10.18231/j.jdpo.2020.071
3
Yong-Shuang Li, Qiang Xie, Da-Ye Yang, Yuan Zheng. RETRACTED ARTICLE: Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studiesMolecular Biology Reports 2014; 41(6): 3925 doi: 10.1007/s11033-014-3260-0
4
Xueyan Dong, Hui He, Weiying Zhang, Daojun Yu, Xianjun Wang, Yueming Chen. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infectionDiagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0317-x
5
Yukie Saeki, Minako Abe, Fumika Kono, Akane Nakazato, Yoshimori Ishihara, Hiroyuki Abe. DNA methylation analysis of cancer-related genes from cell-free DNA of patients with cancerPersonalized Medicine Universe 2017; 6: 4 doi: 10.1016/j.pmu.2017.04.002
6
Mankgopo M. Kgatle, Mashiko Setshedi, Henry N. Hairwadzi. Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular CarcinomaBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3956485
7
L.M.R.B. Arantes, A.C. de Carvalho, M.E. Melendez, C.C. Centrone, J.F. Góis-Filho, T.N. Toporcov, D.N. Caly, E.H. Tajara, E.M. Goloni-Bertollo, A.L. Carvalho. Validation of methylation markers for diagnosis of oral cavity cancerEuropean Journal of Cancer 2015; 51(5): 632 doi: 10.1016/j.ejca.2015.01.060
8
Melissa Frizziero, Mairéad G. McNamara, Angela Lamarca, Rille Pihlak, Roopa Kurup, Richard A. Hubner. Current Translational and Clinical Challenges in Advanced Hepatocellular CarcinomaCurrent Medicinal Chemistry 2020; 27(29): 4789 doi: 10.2174/0929867327666200422143847
9
Xueyan Dong, Qiang Hou, Yueming Chen, Xianjun Wang. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular CarcinomaDisease Markers 2017; 2017: 1 doi: 10.1155/2017/2929381
10
Oscar C. Araújo, Agatha S. Rosa, Arlete Fernandes, Christian Niel, Cristiane A. Villela-Nogueira, Vera Pannain, Natalia M. Araujo, Isabelle A Chemin. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian PatientsPLOS ONE 2016; 11(4): e0153796 doi: 10.1371/journal.pone.0153796
11
Yuling Bin, Yong Ding, Weisheng Xiao, Aijun Liao. RASSF1A: A promising target for the diagnosis and treatment of cancerClinica Chimica Acta 2020; 504: 98 doi: 10.1016/j.cca.2020.01.014
12
Gaeun Kim, Soon Koo Baik. Overview and recent trends of systematic reviews and meta-analyses in hepatologyClinical and Molecular Hepatology 2014; 20(2): 137 doi: 10.3350/cmh.2014.20.2.137
13
Surbhi Jain, Lijia Xie, Batbold Boldbaatar, Selena Y. Lin, James P. Hamilton, Stephen J. Meltzer, Shun‐Hua Chen, Chi‐Tan Hu, Timothy M. Block, Wei Song, Ying‐Hsiu Su. Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesisHepatology Research 2015; 45(11): 1110 doi: 10.1111/hepr.12449